27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Gainers
- Vapotherm (NYSE:VAPO) shares increased by 30.0% to $1.62 during Wednesday's regular session. Trading volume for this security as of 13:30 EST is 153.1K, which is 91.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $43.3 million.
- Cosmos Holdings (NASDAQ:COSM) stock increased by 26.0% to $0.11. As of 13:30 EST, this security is trading at a volume of 75.1 million shares, making up 1604.3% of its average full-day volume over the last 100 days. The company's market cap stands at $9.7 million.
- Geovax Labs (NASDAQ:GOVX) stock increased by 17.89% to $1.03. Geovax Labs's stock is trading at a volume of 16.9 million shares as of 13:30 EST. This is 81.2% of its average full-day volume over the last 100 days. The company's market cap stands at $25.4 million.
- Femasys (NASDAQ:FEMY) shares increased by 16.98% to $1.24. The market value of their outstanding shares is at $14.6 million.
- Ikena Oncology (NASDAQ:IKNA) stock moved upwards by 16.02% to $3.33. The company's market cap stands at $120.7 million.
- Seres Therapeutics (NASDAQ:MCRB) shares rose 15.85% to $6.68. Seres Therapeutics's stock is trading at a volume of 746.3K shares as of 13:30 EST. This is 73.8% of its average full-day volume over the last 100 days. The company's market cap stands at $829.4 million.
Losers
- ThermoGenesis Holdings (NASDAQ:THMO) stock decreased by 47.0% to $0.12 during Wednesday's regular session. As of 13:30 EST, ThermoGenesis Holdings's stock is trading at a volume of 10.3 million, which is 671.2% of its average full-day volume over the last 100 days. The company's market cap stands at $3.7 million.
- Y-mAbs Therapeutics (NASDAQ:YMAB) stock decreased by 23.54% to $11.6. As of 13:30 EST, this security is trading at a volume of 891.4K shares, making up 326.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $507.1 million.
- Taysha Gene Therapies (NASDAQ:TSHA) stock declined by 22.66% to $2.31. Taysha Gene Therapies's stock is trading at a volume of 6.5 million shares as of 13:30 EST. This is 428.6% of its average full-day volume over the last 100 days. The company's market cap stands at $94.7 million.
- Tricida (NASDAQ:TCDA) shares decreased by 19.35% to $0.45. Tricida's stock is trading at a volume of 27.4 million shares as of 13:30 EST. This is 996.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $24.7 million.
- Revelation Biosciences (NASDAQ:REVB) shares fell 17.01% to $0.34. As of 13:30 EST, Revelation Biosciences's stock is trading at a volume of 3.6 million, which is 99.6% of its average full-day volume over the last 100 days. The company's market cap stands at $8.0 million.
- Gelesis Holdings (NYSE:GLS) stock decreased by 16.71% to $0.42. The current volume of 86.7K shares is 75.2% of Gelesis Holdings's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $30.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!